Company: OSRH
Filing Date: 2025-01-24
Form Type: S-4/A
Source: 0001213900-25-006139
Chunk: 221

Company: OSR Holdings, Inc.
Filing Date: 2025-01-24
Form: S-4/A
Chunk 221
---
 to product candidates that we intend to commercialize that are not covered by the patents that we exclusively licensed and have the right to enforce; •we, our licensor or any collaborators might not have been the first to make or reduce to practice the inventions covered by the issued patents or pending patent applications that we own or have exclusively licensed; •we or our licensor or any collaborators might not have been the first to file patent applications covering certain of our inventions; •others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our intellectual property rights; •issued patents that we own or have exclusively licensed may not provide us with any competitive advantages, or may be held invalid or unenforceable as a result of legal challenges; •our competitors might conduct research and development activities in the United States and other countries that provide a safe harbor from patent infringement claims for certain research and development activities, as well as in countries where we do not have patent rights, and then use the information learned from such activities to develop competitive product candidates for sale in our major commercial markets; and we may not develop additional proprietary technologies that are patentable; •third parties performing manufacturing or testing for us using our product candidates or technologies could use the intellectual property of others without obtaining a proper license; •parties may assert an ownership interest in our intellectual property and, if successful, such disputes may preclude us from exercising exclusive rights over that intellectual property; •we may not develop or in -licenseadditional proprietary technologies that are patentable; •we may not be able to obtain and maintain necessary licenses on commercially reasonable terms, or at all; •the patents of others may harm our business; and •we may choose not to file a patent application in order to maintain certain trade secrets or know -how, and a third party may subsequently file a patent application covering such intellectual property. Should any of these events occur, they could significantly harm our business and results of operations. 119 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Introduction On May 23, 2024, BLAC and OSR Holdings entered into an Amended & Restated Business Combination Agreement. The Amended and Restated Business Combination Agreement was amended on December 20, 2024. The following unaudited pro forma condensed combined financial information (the “ Pro Forma Information”) gives effect to the Business Combination and the other events described below. The Business Combination will be accounted for as a reverse recapitalization in accordance with U.S